BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation. 1998

R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Department of Nephrology, G. Gaslini Children's Institute, Origgio, Italy.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007223 Infant A child between 1 and 23 months of age. Infants
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships.
August 1998, Transplantation proceedings,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
August 1998, Transplantation proceedings,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
March 1996, Transplantation,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantation.
January 1996, Transplant international : official journal of the European Society for Organ Transplantation,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.
October 1994, Transplantation proceedings,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
December 1996, Transplantation proceedings,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Neoral: a microemulsion cyclosporine.
March 1996, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO),
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Neoral: the microemulsion formulation.
May 1998, Pediatric transplantation,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
August 1998, Transplantation proceedings,
R Gusmano, and G C Basile, and F Perfumo, and F Ginevri, and E Verrina, and L Famularo, and G Corbetta
Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
September 2001, Transplantation,
Copied contents to your clipboard!